Scroll to top

News

CLINUVEL
Posted by CLINUVEL
February 10, 2016

SCENESSE® receives US FDA orphan designation for cutaneous porphyrias

10 February 2016 Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY)...

Read More
CLINUVEL
Posted by CLINUVEL
February 7, 2016

Presentation to international porphyria patient group

8 February 2016 Clinuvel Pharmaceuticals Ltd (ASX: CUV; XETRA‐DAX: UR9; ADR: CLVLY)...

Read More
CLINUVEL
Posted by CLINUVEL
January 28, 2016

Appendix 4C - Q2 FY16

28 January 2016 Enclosed is a copy of the Quarterly report for...

Read More
CLINUVEL
Posted by CLINUVEL
January 25, 2016

Form 604

25 January 2016 Enclosed is a notice of a change of interest...

Read More
CLINUVEL
Posted by CLINUVEL
January 20, 2016

CEO Brief - January 20, 2016

20 January 2016 Having both received and provided services within the healthcare...

Read More
CLINUVEL
Posted by CLINUVEL
January 18, 2016

Form 604

18 January 2016 Enclosed is a notice of change of interests of...

Read More
We use cookies to give you the best experience.